RELAPSED/REFRACTORY AML
Clinical trials for RELAPSED/REFRACTORY AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY AML trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'Universal' immune cells to battle tough leukemia
Disease control Not yet recruitingThis study is testing a new treatment for acute myeloid leukemia (AML) that has returned or not responded to other therapies. It uses specially engineered immune cells from a healthy donor, designed to find and attack the cancer. The first part finds the safest dose, and the seco…
Matched conditions: RELAPSED/REFRACTORY AML
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat leukemia patients
Disease control Not yet recruitingThis study is testing a drug called olutasidenib for adults with a specific type of acute myeloid leukemia (AML) that has returned or stopped responding to treatment. The goal is to see if the drug can help control the cancer and improve blood counts. About 25 people who have alr…
Matched conditions: RELAPSED/REFRACTORY AML
Phase: PHASE2 • Sponsor: Timothy Pardee • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC